Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 148 articles:
HTML format



Single Articles


    July 2021

  1. Nutritional basis of type 2 diabetes remission.
    BMJ. 2021;374:n1752.
    PubMed    


  2. TAYLOR R, Ramachandran A, Yancy WS Jr, Forouhi NG, et al
    Nutritional basis of type 2 diabetes remission.
    BMJ. 2021;374:n1449.
    PubMed    


    June 2021
  3. IACOBUCCI G
    NHS to trial "artificial pancreas" for patients with type 1 diabetes.
    BMJ. 2021;373:n1538.
    PubMed    


    May 2021
  4. FREY E, Bonfiglioli C, Frawley J
    Self-management: diabetes care is getting social.
    BMJ. 2021;373:n1333.
    PubMed    



  5. Newer drug treatments for type 2 diabetes.
    BMJ. 2021;373:n1326.
    PubMed    


  6. GOLDENBERG JZ, Johnston BC
    Low and very low carbohydrate diets for diabetes remission.
    BMJ. 2021;373:n262.
    PubMed    


  7. WISE J
    Diabetes: BMI cut-offs designed to trigger action are too high for some ethnic populations, say researchers.
    BMJ. 2021;373:n1217.
    PubMed    


  8. LI S, Vandvik PO, Lytvyn L, Guyatt GH, et al
    SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2021;373:n1091.
    PubMed     Abstract available


  9. GUO J, Smith SM
    Newer drug treatments for type 2 diabetes.
    BMJ. 2021;373:n1171.
    PubMed    


  10. NASIR K, Cainzos-Achirica M
    Role of coronary artery calcium score in the primary prevention of cardiovascular disease.
    BMJ. 2021;373:n776.
    PubMed     Abstract available


    March 2021
  11. CASASSUS B
    Drug company Servier is found guilty of manslaughter and aggravated deceit over Mediator diabetes drug.
    BMJ. 2021;372:n873.
    PubMed    


  12. AYOUBKHANI D, Khunti K, Nafilyan V, Maddox T, et al
    Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    BMJ. 2021;372:n693.
    PubMed     Abstract available


  13. JONES A, Wu JHY, Buse K
    UK's sugar tax hits the sweet spot.
    BMJ. 2021;372:n463.
    PubMed    


    January 2021
  14. PALMER SC, Tendal B, Mustafa RA, Vandvik PO, et al
    Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2021;372:m4573.
    PubMed     Abstract available


  15. GOLDENBERG JZ, Day A, Brinkworth GD, Sato J, et al
    Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.
    BMJ. 2021;372:m4743.
    PubMed     Abstract available


  16. DOWNS J
    Please see the whole picture of my eating disorder.
    BMJ. 2021;372:m4569.
    PubMed    


    December 2020
  17. DELICANO RA, Hammar U, Egenvall A, Westgarth C, et al
    The shared risk of diabetes between dog and cat owners and their pets: register based cohort study.
    BMJ. 2020;371:m4337.
    PubMed     Abstract available


    November 2020
  18. IACOBUCCI G
    Every hospital should have a specialist diabetes inpatient team, says review.
    BMJ. 2020;371:m4441.
    PubMed    


  19. MUSSO G, Saba F, Cassader M, Gambino R, et al
    Diabetic ketoacidosis with SGLT2 inhibitors.
    BMJ. 2020;371:m4147.
    PubMed    


    September 2020
  20. HILL NE, Oliver NS
    Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m3772.
    PubMed    


  21. FILION KB, Lix LM, Yu OH, Dell'Aniello S, et al
    Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
    BMJ. 2020;370:m3342.
    PubMed     Abstract available


    August 2020
  22. FRALICK M, Kim SC, Schneeweiss S, Everett BM, et al
    Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study.
    BMJ. 2020;370:m2812.
    PubMed     Abstract available


  23. BUTLER AE, Misselbrook D
    Distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m2998.
    PubMed    


    July 2020
  24. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    PubMed     Abstract available


  25. HU Y, Ding M, Sampson L, Willett WC, et al
    Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies.
    BMJ. 2020;370:m2206.
    PubMed     Abstract available


  26. ZHENG JS, Sharp SJ, Imamura F, Chowdhury R, et al
    Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.
    BMJ. 2020;370:m2194.
    PubMed     Abstract available


  27. BURNS VF
    I live with "the world's most dangerous" eating disorder.
    BMJ. 2020;370:m1886.
    PubMed    


    June 2020
  28. MCMILLAN B, Boyd J, Mitchell C
    Enhancing postnatal care of women with gestational diabetes.
    BMJ. 2020;369:m2414.
    PubMed    


  29. KAR P
    Partha Kar: Covid-19-time for parity in commissioning diabetes services.
    BMJ. 2020;369:m2154.
    PubMed    


    May 2020
  30. VOUNZOULAKI E, Khunti K, Abner SC, Tan BK, et al
    Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
    BMJ. 2020;369:m1361.
    PubMed     Abstract available


  31. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    PubMed     Abstract available


    April 2020
  32. BHASALE A, Mintzes B, Sarpatwari A
    Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.
    BMJ. 2020;369:m1107.
    PubMed    


  33. PASTERNAK B, Wintzell V, Melbye M, Eliasson B, et al
    Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.
    BMJ. 2020;369:m1186.
    PubMed     Abstract available


  34. LI Y, Teng D, Shi X, Qin G, et al
    Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.
    BMJ. 2020;369:m997.
    PubMed     Abstract available


  35. MATHIESON S, Lin CC, Underwood M, Eldabe S, et al
    Pregabalin and gabapentin for pain.
    BMJ. 2020;369:m1315.
    PubMed    


  36. DIAB J, Bannan A, Pollitt T
    Necrotising fasciitis.
    BMJ. 2020;369:m1428.
    PubMed    


    March 2020

  37. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1270.
    PubMed    


  38. IACOBUCCI G
    Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears.
    BMJ. 2020;368:m1262.
    PubMed    


  39. EXTANCE A
    Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1174.
    PubMed    


  40. VALABHJI J
    Rapid access to multidisciplinary diabetes foot care teams.
    BMJ. 2020;368:m773.
    PubMed    


    February 2020
  41. MCCORMACK JP, Holmes DT
    Your results may vary: the imprecision of medical measurements.
    BMJ. 2020;368:m149.
    PubMed    


  42. ROY MP
    Improving nutrition in India: encouraging informed food choices.
    BMJ. 2020;368:m367.
    PubMed    


  43. VAN DUINEN GL
    Healthy lifestyle and life expectancy: fund prevention programmes to end the cycle of preventable morbidity.
    BMJ. 2020;368:m427.
    PubMed    


  44. CRAIG MF
    We shouldn't recommend harmful foods "in moderation".
    BMJ. 2020;368:m365.
    PubMed    


    January 2020
  45. FEINMANN J
    Hope for diabetes: five minutes with David Unwin.
    BMJ. 2020;368:m404.
    PubMed    


  46. COOK R, Davidson P, Martin R
    Losing weight following diagnosis of type 2 diabetes boosts chance of remission.
    BMJ. 2020;368:l6775.
    PubMed     Abstract available


  47. KAR P
    Partha Kar: What will the 2020s hold for diabetes care?
    BMJ. 2020;368:m202.
    PubMed    


  48. LI Y, Schoufour J, Wang DD, Dhana K, et al
    Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study.
    BMJ. 2020;368:l6669.
    PubMed     Abstract available


    December 2019
  49. YU Y, Arah OA, Liew Z, Cnattingius S, et al
    Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up.
    BMJ. 2019;367:l6398.
    PubMed     Abstract available


    November 2019
  50. RODRIGUEZ-GUTIERREZ R, Gonzalez-Gonzalez JG, Zuniga-Hernandez JA, McCoy RG, et al
    Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    BMJ. 2019;367:l5887.
    PubMed     Abstract available


    October 2019
  51. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.
    PubMed    


  52. SPILSBURY C, Panahi M, Bowsher G, Sadighi A, et al
    A young woman with dyspnoea and oedema.
    BMJ. 2019;367:l5763.
    PubMed    


  53. IACOBUCCI G
    Diabetes technology: specialists are blocking access for some patients, say experts.
    BMJ. 2019;367:l6085.
    PubMed    



  54. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;367:l5612.
    PubMed    


  55. IACOBUCCI G
    Thousands more patients with type 1 diabetes are getting flash glucose devices, data show.
    BMJ. 2019;367:l5895.
    PubMed    


    September 2019
  56. HENDERSON G
    Whether one burns fat, and not the type of fat one eats, is the important thing in type 2 diabetes.
    BMJ. 2019;366:l5700.
    PubMed    


  57. HOOPER L, Brown T, Brainard J, Abdelhamid A, et al
    Authors' reply to Henderson.
    BMJ. 2019;366:l5703.
    PubMed    


  58. LEAN M, McCombie L, McSorely J
    Trends in type 2 diabetes.
    BMJ. 2019;366:l5407.
    PubMed    


  59. MAGLIANO DJ, Islam RM, Barr ELM, Gregg EW, et al
    Trends in incidence of total or type 2 diabetes: systematic review.
    BMJ. 2019;366:l5003.
    PubMed     Abstract available


    August 2019
  60. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    PubMed     Abstract available


  61. LIND M, Pivodic A, Svensson AM, Olafsdottir AF, et al
    HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
    BMJ. 2019;366:l4894.
    PubMed     Abstract available


  62. BROWN TJ, Brainard J, Song F, Wang X, et al
    Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    BMJ. 2019;366:l4697.
    PubMed     Abstract available


  63. MAHASE E
    Progress in diabetes care has not improved outcomes in US, study finds.
    BMJ. 2019;366:l5166.
    PubMed    


    July 2019
  64. MERINO J
    Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;366:l4292.
    PubMed     Abstract available


  65. NEUENSCHWANDER M, Ballon A, Weber KS, Norat T, et al
    Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
    BMJ. 2019;366:l2368.
    PubMed     Abstract available


  66. JIAO J, Liu G, Shin HJ, Hu FB, et al
    Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
    BMJ. 2019;366:l4009.
    PubMed     Abstract available


    June 2019
  67. WISE J
    The wrong diabetes: how C peptide testing might help.
    BMJ. 2019;365:l4352.
    PubMed    


  68. SHEIKH Z, Akali A
    An unstable lump in the groin.
    BMJ. 2019;365:l2214.
    PubMed    


    May 2019
  69. KARSLIOGLU FRENCH E, Donihi AC, Korytkowski MT
    Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
    BMJ. 2019;365:l1114.
    PubMed     Abstract available


    April 2019
  70. MAHASE E
    Dentists could help detect diabetes and cardiovascular disease during oral health checks.
    BMJ. 2019;365:l1870.
    PubMed    


  71. BARRY E, Finnikin S
    A borderline HBA1c result.
    BMJ. 2019;365:l1361.
    PubMed    


  72. WEI L, Lai EC, Kao-Yang YH, Walker BR, et al
    Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study.
    BMJ. 2019;365:l1204.
    PubMed     Abstract available


  73. MUSSO G, Gambino R, Cassader M, Paschetta E, et al
    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    BMJ. 2019;365:l1328.
    PubMed     Abstract available


  74. BLAIR JC, McKay A, Ridyard C, Thornborough K, et al
    Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    BMJ. 2019;365:l1226.
    PubMed     Abstract available


    March 2019
  75. WISE J
    The BMJ Awards 2019: Diabetes Team of the Year.
    BMJ. 2019;364:l1232.
    PubMed    


  76. IACOBUCCI G
    Sixty seconds on . . . reversing type 2 diabetes.
    BMJ. 2019;364:l1128.
    PubMed    


  77. NEWMAN M
    Questions over future of global diabetes group as founding members resign.
    BMJ. 2019;364:l995.
    PubMed    


    February 2019
  78. LEVY M, Prentice M, Wass J
    Diabetes insipidus.
    BMJ. 2019;364:l321.
    PubMed    


  79. FEINMANN J
    Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes.
    BMJ. 2019;364:l659.
    PubMed    


  80. SCIBILIA R, Aldred C
    #TalkAboutComplications.
    BMJ. 2019;364:k5258.
    PubMed    


    January 2019
  81. KMIETOWICZ Z
    Fried food linked to increased risk of death among older US women.
    BMJ. 2019;364:l362.
    PubMed    


  82. IACOBUCCI G
    Sixty seconds on . . . medical detection dogs.
    BMJ. 2019;364:l302.
    PubMed    


  83. MAYOR S
    Delivering diabetes targets: five minutes with . . . Sam Everington.
    BMJ. 2019;364:l229.
    PubMed    


  84. MANFREDINI R, Cappadona R, Fabbian F
    Nurses, shift work, and diabetes: should late chronotype be considered as a risk factor?
    BMJ. 2019;364:l178.
    PubMed    


  85. SKOVENBORG E
    Shift work and diabetes: alcohol consumption as a risk factor.
    BMJ. 2019;364:l177.
    PubMed    


  86. SHAN Z, Bhupathiraju SN
    Authors' reply to Skovenborg and Manfredini and colleagues.
    BMJ. 2019;364:l179.
    PubMed    


  87. PILLING LC, Tamosauskaite J, Jones G, Wood AR, et al
    Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
    BMJ. 2019;364:k5222.
    PubMed     Abstract available


  88. MAYOR S
    Diabetes: precision approach will improve outcomes, says research director.
    BMJ. 2019;364:l186.
    PubMed    


  89. SALISBURY H
    Helen Salisbury: When policy doesn't match evidence.
    BMJ. 2019;364:l54.
    PubMed    


    December 2018
  90. CHARLTON M
    Everyone with type 1 diabetes should have access to a flash glucose device.
    BMJ. 2018;363:k5204.
    PubMed    


  91. BLACK S
    Flash glucose monitoring devices: CCG criteria are incoherent.
    BMJ. 2018;363:k5203.
    PubMed    


  92. ADLER AI
    Incretins and cancer of the bile duct in type 2 diabetes.
    BMJ. 2018;363:k5155.
    PubMed    


  93. ABRAHAMI D, Douros A, Yin H, Yu OH, et al
    Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;363:k4880.
    PubMed     Abstract available


    November 2018
  94. FEINMANN J
    Type 2 diabetes: 5000 patients to test feasibility of "remission service".
    BMJ. 2018;363:k5114.
    PubMed    


  95. HENDLEY J
    Are you well controlled?
    BMJ. 2018;363:k3119.
    PubMed    


  96. SHAN Z, Li Y, Zong G, Guo Y, et al
    Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses.
    BMJ. 2018;363:k4641.
    PubMed     Abstract available


  97. IACOBUCCI G
    Type 2 diabetes affects 7000 young people in England and Wales, analysis shows.
    BMJ. 2018;363:k4929.
    PubMed    


  98. KMIETOWICZ Z
    Type 2 diabetes: sweetened drinks pose greater risk than other sugary foods.
    BMJ. 2018;363:k4943.
    PubMed    


  99. CHOO VL, Viguiliouk E, Blanco Mejia S, Cozma AI, et al
    Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.
    BMJ. 2018;363:k4644.
    PubMed     Abstract available


  100. SODI R, McKay K, Dampetla S, Pappachan JM, et al
    Monitoring glycaemic control in patients with diabetes mellitus.
    BMJ. 2018;363:k4723.
    PubMed    


  101. KMIETOWICZ Z
    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.
    PubMed    


  102. UEDA P, Svanstrom H, Melbye M, Eliasson B, et al
    Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ. 2018;363:k4365.
    PubMed     Abstract available


  103. IACOBUCCI G
    NHS England tells CCGs to end postcode lottery over diabetes glucose devices.
    BMJ. 2018;363:k4812.
    PubMed    


  104. OWEN J
    Audit paints "bleak picture" of diabetes care in England and Wales.
    BMJ. 2018;363:k4780.
    PubMed    


  105. IACOBUCCI G
    Patients with type 1 diabetes are missing out on flash glucose devices, finds BMJ investigation.
    BMJ. 2018;363:k4675.
    PubMed    


  106. MILLETT ERC, Peters SAE, Woodward M
    Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    BMJ. 2018;363:k4247.
    PubMed     Abstract available


    October 2018
  107. KHANDWALA YS, Baker VL, Shaw GM, Stevenson DK, et al
    Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study.
    BMJ. 2018;363:k4372.
    PubMed     Abstract available


    September 2018
  108. MIETTINEN ME, Virtanen SM
    Dietary gluten and type 1 diabetes.
    BMJ. 2018;362:k3867.
    PubMed    


  109. ANTVORSKOV JC, Halldorsson TI, Josefsen K, Svensson J, et al
    Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark.
    BMJ. 2018;362:k3547.
    PubMed     Abstract available


  110. RAMOS R, Comas-Cufi M, Marti-Lluch R, Ballo E, et al
    Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    BMJ. 2018;362:k3359.
    PubMed     Abstract available


  111. XU G, Liu B, Sun Y, Du Y, et al
    Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
    BMJ. 2018;362:k1497.
    PubMed     Abstract available


    August 2018
  112. MAYOR S
    Type 1 diabetes: earlier onset is linked to cardiovascular complications and reduced lifespan.
    BMJ. 2018;362:k3487.
    PubMed    


  113. WISE J
    Diabetes: simple patient characteristics should help inform choice of second line drug, study finds.
    BMJ. 2018;362:k3368.
    PubMed    


    July 2018
  114. MCGOWAN LD, Roumie CL
    Sulfonylureas as second line treatment for type 2 diabetes.
    BMJ. 2018;362:k3041.
    PubMed    


  115. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    PubMed     Abstract available


  116. FEGHALI MN, Scifres CM
    Novel therapies for diabetes mellitus in pregnancy.
    BMJ. 2018;362:k2034.
    PubMed     Abstract available


  117. LUDVIGSSON JF, Neovius M, Soderling J, Gudbjornsdottir S, et al
    Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.
    BMJ. 2018;362:k2638.
    PubMed     Abstract available


    June 2018
  118. ABALEM MF, Eagle KA, Rao RC
    Unilateral retinopathy in a patient with diabetes and coronary heart disease.
    BMJ. 2018;361:k1703.
    PubMed    


  119. FOROUHI NG, Misra A, Mohan V, Taylor R, et al
    Dietary and nutritional approaches for prevention and management of type 2 diabetes.
    BMJ. 2018;361:k2234.
    PubMed    


    May 2018
  120. DOBSON R, Whittaker R, Jiang Y, Maddison R, et al
    Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    BMJ. 2018;361:k1959.
    PubMed     Abstract available


    April 2018
  121. CARRUTH L, Mendenhall E
    Social aetiologies of type 2 diabetes.
    BMJ. 2018;361:k1795.
    PubMed    


  122. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    PubMed     Abstract available


  123. WAUGH N, Adler A, Craigie I, Omer T, et al
    Closed loop systems in type 1 diabetes.
    BMJ. 2018;361:k1613.
    PubMed    


  124. BEKIARI E, Kitsios K, Thabit H, Tauschmann M, et al
    Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    BMJ. 2018;361:k1310.
    PubMed     Abstract available


    March 2018
  125. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study.
    BMJ. 2018;360:k1046.
    PubMed     Abstract available


  126. HAWKES N
    Sixty seconds on . . . diabetes.
    BMJ. 2018;360:k1264.
    PubMed    


  127. ABRAHAMI D, Douros A, Yin H, Yu OHY, et al
    Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;360:k872.
    PubMed     Abstract available


  128. WISE J
    NHS diabetes prevention programme helps weight loss, analysis shows.
    BMJ. 2018;360:k1196.
    PubMed    


    February 2018
  129. PATORNO E, Goldfine AB, Schneeweiss S, Everett BM, et al
    Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study.
    BMJ. 2018;360:k119.
    PubMed     Abstract available


  130. MORLEY RL, Sharma A, Horsch AD, Hinchliffe RJ, et al
    Peripheral artery disease.
    BMJ. 2018;360:j5842.
    PubMed    


    January 2018
  131. TU H, Wen CP, Tsai SP, Chow WH, et al
    Cancer risk associated with chronic diseases and disease markers: prospective cohort study.
    BMJ. 2018;360:k134.
    PubMed     Abstract available


  132. WISE J
    NHS weight management programme makes clinical difference in patients with type 2 diabetes.
    BMJ. 2018;360:k177.
    PubMed    


  133. WENG J, Zhou Z, Guo L, Zhu D, et al
    Incidence of type 1 diabetes in China, 2010-13: population based study.
    BMJ. 2018;360:j5295.
    PubMed     Abstract available


    December 2017
  134. KMIETOWICZ Z
    GP based weight loss programme can reverse type 2 diabetes.
    BMJ. 2017;359:j5641.
    PubMed    


  135. WISE J
    Study links varicoceles to heart disease and diabetes.
    BMJ. 2017;359:j5569.
    PubMed    


    November 2017
  136. HIPPISLEY-COX J, Coupland C
    Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    BMJ. 2017;359:j5019.
    PubMed     Abstract available


  137. MISHRA SC, Chhatbar KC, Kashikar A, Mehndiratta A, et al
    Diabetic foot.
    BMJ. 2017;359:j5064.
    PubMed    


  138. HAWKES N
    Sixty seconds on . . . semaglutide.
    BMJ. 2017;359:j5010.
    PubMed    


    October 2017
  139. KALLIALA I, Markozannes G, Gunter MJ, Paraskevaidis E, et al
    Obesity and gynaecological and obstetric conditions: umbrella review of the literature.
    BMJ. 2017;359:j4511.
    PubMed     Abstract available


  140. MAYOR S
    Type 3c diabetes associated with pancreatic disease is often misdiagnosed, finds study.
    BMJ. 2017;359:j4923.
    PubMed    


  141. MAYOR S
    GP referral to prevention programme helps prevent type 2 diabetes, study finds.
    BMJ. 2017;359:j4770.
    PubMed    


  142. MARJOT D
    Hunger can be the driving force behind "relapse" of type 2 diabetes.
    BMJ. 2017;359:j4728.
    PubMed    


  143. COUSINS S
    Diabetic patients with poor glycaemic control have higher risk of latent TB, study shows.
    BMJ. 2017;359:j4767.
    PubMed    


    September 2017
  144. MAYOR S
    Obesity surgery achieves long term weight loss and prevents type 2 diabetes, study finds.
    BMJ. 2017;358:j4376.
    PubMed    


  145. GULLAND A
    People at high risk of diabetes should undergo intensive lifestyle change, says NICE.
    BMJ. 2017;358:j4301.
    PubMed    


  146. MAYOR S
    Twenty four hour glucose monitoring halves adverse birth outcomes in pregnant women with type 1 diabetes, study finds.
    BMJ. 2017;358:j4294.
    PubMed    


  147. MCCOMBIE L, Leslie W, Taylor R, Kennon B, et al
    Beating type 2 diabetes into remission.
    BMJ. 2017;358:j4030.
    PubMed    


  148. DYER O
    France to prosecute its drug regulator and Servier in scandal over diabetes drug.
    BMJ. 2017;358:j4231.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: